Market Tracker

05/29 4:01am ET

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.33
Delayed Data
As of May 28
 -0.07 / -2.92%
Today’s Change
1.00
Today|||52-Week Range
8.46
-8.63%
Year-to-Date

Today’s Trading

Previous close2.40
Today’s open2.38
Day’s range2.32 - 2.41
Volume735,631
Average volume (3 months)1,010,052
Market cap$175.1M
Dividend yield--
Data as of 4:00pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)-15.15%
Earnings growth (this year)+29.14%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.93%
P/E ratioNM
Price/Sales26.71
Price/Book11.49

Competitors

 Today’s
change
Today’s
% change
XENEXenon Pharmaceutical...+0.79+6.39%
--Ecogreen Fine Chemic...-0.01-4.25%
MDGNMedgenics Inc+0.19+2.74%
ANTHAnthera Pharmaceutic...+0.31+6.07%
Data as of 4:01pm ET, 05/28/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$5.7M
Annual profit (last year)-$43.0M
Net profit margin-749.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts